13 Results

People

  1. Curran
    Curran
  2. Ahmed
    Ahmed
  3. Babady
    Babady
  4. Barker
    Barker
  5. Chung
    Chung
  6. Dahi
    Dahi
  7. Devlin
    Devlin
  8. Dewolf
    Dewolf
  9. Diamond
    Diamond
  10. Durham
    Durham

Groups

  1. Hematologic Malignancies, Division of (5)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. Pediatrics, Department of (4)
  5. Stem Cell Transplantation and Cellular Therapy Service (4)
  6. Department of Pathology and Laboratory Medicine (3)
  7. Bone Marrow Transplant (2)
  8. CTCR Scholars (2)
  9. Hematology-Oncology Fellows (2)
  10. Adult Leukemia (1)
  1. "anakinra"
Formats
  1. Journal Article (10)
  2. Review (2)
  3. Correspondence (1)
Groups
  1. Hematologic Malignancies, Division of (5)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. Pediatrics, Department of (4)
  5. Stem Cell Transplantation and Cellular Therapy Service (4)
  6. Department of Pathology and Laboratory Medicine (3)

More Groups

People
  1. Kevin Curran (3)
  2. Benjamin Durham (1)
  3. Bianca Santomasso (1)
  4. David Chung (1)
  5. David Nemirovsky (1)
  6. Elena Mead (1)

More People

Years
  1. 2025 (4)
  2. 2024 (3)
  3. 2023 (2)
  4. 2022 (3)
  5. 2020 (1)
Publications
  1. Blood Advances (3)
  2. Blood (2)
  3. Blood Cancer Journal (1)
  4. Hematology/Oncology Clinics of North America (1)
  5. Journal of Clinical Oncology (1)
  6. Journal of Critical Care (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Elsevier Inc. (3)
  3. Nature Publishing Group (2)
  4. American Society of Clinical Oncology (1)
  5. Taylor & Francis Group (1)
  6. W.B. Saunders Co. (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS)
    Review

    Lee, J. C.; Johnson, W. T.; Hines, M.; Shah, N. N.
    Hematology/Oncology Clinics of North America (2025)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of B-cell maturation antigen (BCMA) NEX-T® chimeric antigen receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma
    Journal Article

    Ravi, G.; Richard, S.; Kumar, S.; Atrash, S.; Liedtke, M.; Kaur, G.; Derman, B.; Bergsagel, P. L.; Mailankody, S.; McCarthy, P.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: Outcomes from an international, retrospective cohort study
    Journal Article

    Matt, M. G.; Drozdov, D.; Bendstrup, E.; Glerup, M.; Hauge, E. M.; Masmas, T.; Schneider, E. C.; Zeilhofer, U. B.; Abu-Arja, R. F.; Driest, K. D.; more...
    The Lancet Rheumatology (2025)

    Fulltext@MSK | Save
  • Outcomes after brexucabtagene autoleucel administered as a standard therapy for adults with relapsed/refractory B-cell ALL
    Journal Article

    Roloff, G. W.; Aldoss, I.; Kopmar, N. E.; Lin, C.; Dekker, S. E.; Gupta, V. K.; O’Connor, T. E.; Jeyakumar, N.; Muhsen, I. N.; Valtis, Y.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Impact of extraosseous extramedullary disease on outcomes of patients with relapsed-refractory multiple myeloma receiving standard-of-care chimeric antigen receptor T-cell therapy
    Journal Article

    Dima, D.; Abdallah, A. O.; Davis, J. A.; Awada, H.; Goel, U.; Rashid, A.; DeJarnette, S.; Anwer, F.; Shune, L.; Raza, S.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • A robust quality infrastructure is key to safe and effective delivery of immune effector cells: How FACT-finding can help
    Review

    Curran, K. J.; Nikiforow, S.; Bachier, C.; Hsu, Y. M.; Maloney, D.; Maus, M. V.; McCarthy, P.; Porter, D.; Shi, P.; Shpall, E. J.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy
    Journal Article

    Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
    Journal Article

    McNerney, K. O.; Si Lim, S. J.; Ishikawa, K.; Dreyzin, A.; Vatsayan, A.; Chen, J. J.; Baggott, C.; Prabhu, S.; Pacenta, H. L.; Philips, C.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • How I treat unique and difficult-to-manage cases of CAR T-cell therapy–associated neurotoxicity
    Journal Article

    Santomasso, B. D.; Gust, J.; Perna, F.
    Blood (2023)

    Fulltext@MSK | Save
  • ALK-positive histiocytosis: A new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
    Journal Article

    Kemps, P. G.; Picarsic, J.; Durham, B. H.; Hélias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; van den Bos, C.; van de Wetering, M. D.; van Noesel, C. J. M.; van Laar, J. A. M.; Verdijk, R. M.; more...
    Blood (2022)

    Fulltext@MSK | Save